Los Angeles Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Los Angeles Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-26,520	Closed	-$1.4M	–	1576
2020 Q3	$1.4M	Sell	26,520 -975	-4%	-$60.2K	0.01%	689
2020 Q2	$1.69M	Buy	27,495 +14,916	+119%	+$863K	0.01%	661
2020 Q1	$712K	Buy	+12,579	New	+$717K	﹤0.01%	803
2019 Q1	–	Sell	-4,734	Closed	-$287K	–	1466
2018 Q4	$287K	Sell	4,734 -125	-3%	-$7.47K	﹤0.01%	1121
2018 Q3	$284K	Hold	4,859	–	–	﹤0.01%	1238
2018 Q2	$218K	Hold	4,859	–	–	﹤0.01%	1364
2018 Q1	$215K	Hold	4,859	–	–	﹤0.01%	1255
2017 Q4	$211K	Buy	4,859 +75	+2%	+$3.37K	﹤0.01%	1259
2017 Q3	$223K	Buy	+4,784	New	+$229K	﹤0.01%	1229

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Los Angeles Capital Management's BSTC Position: Q4 2020 in Review

Los Angeles Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 26,520 shares — an estimated $1.4M sold.

Los Angeles Capital Management first reported a position in BSTC in Q3 2017 and held it in 9 quarters. The position peaked at $1.69M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Los Angeles Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Los Angeles Capital Management sold 26,520 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.4M.
Los Angeles Capital Management first reported a position in BioSpecifics Technologies Corp. in Q3 2017 and held it in 9 quarters.
Los Angeles Capital Management's BioSpecifics Technologies Corp. position peaked at $1.69M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Los Angeles Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.